非ST段NSTE-ACS患者血清降钙素原与冠脉病变的相关性分析

doi:10.19485/j.cnki.issn1007-0931.2017.08.019

Preventive Medicine

2017, Vol. 29

Issue (8): 820-822 DOI: 10.19485/j.cnki.issn1007-0931.2017.08.019

Current Issue | Archive | Adv Search

Abstract
Figure/Table
References
Related Citation (8)

[1] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2015》概要[J]. 中国循环杂志,2016,31（6）：521-528.
[2] MCMANUS D D,GORE J,YARZEBSKI J,et al. Recent trends in the incidence,treatment,and outcomes of patients with STEMI and NSTEMI[J]. Am J Med,2011,124（1）：40-47.
[3] BEKTAS F,SOYUNCU S,GUNDUZ I,et al. The value of procalcitonin,a novel inflammatory marker,in the diagnosis of myocardial infarction and evaluation of acute coronary syndrome patients[J]. J Emerg Med,2011,41（5）：524-530.
[4] ERTEM A G,EFE T H,YAYLA C,et al. The association between serum procalcitonin levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute coronary syndrome[J]. Angiology,2017,68（1）：40-45.
[5] AMSTERDAM E A,WENGER N K,BRINDIS R G,et al. 2014 AHA/ACC guideline for the management of patients with non-st-elevation acute coronary syndromes：a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J]. Circulation,2014,130（25）：e344-e426.
[6] QIAN J,CAI M,GAO J,et al. Trends in smoking and quitting in China from 1993 to 2003：National Health Service Survey data[J]. Bull World Health Organ,2010,88（10）：769-776.
[7] SECMEER G,DEVRIM I,KARA A,et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia[J]. J Pediatr Hematol Oncol,2007,29（2）：107-111.
[8] 陈灏珠. 内科学[M]. 北京：人民卫生出版社,2008：267,302.
[9] 张晋东,杨海波,赵晓燕,等. 急性冠脉综合征患者血清降钙素原、D-二聚体水平测定[J]. 郑州大学学报（医学版）,2015,50（2）：267-270.
[10] 邓建君,谢萍,侯婷婷,等. 降钙素原与急性心肌梗死患者炎症反应的相关性研究[J]. 中国循环杂志,2015,30（4）：335-338.
[11] SINNING C R,SINNING J M,SCHULZ A,et al. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease[J]. Circ J,2011,75（5）：1184-1191.